
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Evolent Health Inc (EVH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: EVH (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $15.46
1 Year Target Price $15.46
9 | Strong Buy |
4 | Buy |
1 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -37.69% | Avg. Invested days 24 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.12B USD | Price to earnings Ratio - | 1Y Target Price 15.46 |
Price to earnings Ratio - | 1Y Target Price 15.46 | ||
Volume (30-day avg) 14 | Beta 0.81 | 52 Weeks Range 7.06 - 31.88 | Updated Date 08/29/2025 |
52 Weeks Range 7.06 - 31.88 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-07 | When - | Estimate 0.08 | Actual -0.1 |
Profitability
Profit Margin -5.94% | Operating Margin (TTM) 0.64% |
Management Effectiveness
Return on Assets (TTM) -0.21% | Return on Equity (TTM) -11.04% |
Valuation
Trailing PE - | Forward PE 96.15 | Enterprise Value 1817840318 | Price to Sales(TTM) 0.51 |
Enterprise Value 1817840318 | Price to Sales(TTM) 0.51 | ||
Enterprise Value to Revenue 0.83 | Enterprise Value to EBITDA 208.35 | Shares Outstanding 115971000 | Shares Floating 91317991 |
Shares Outstanding 115971000 | Shares Floating 91317991 | ||
Percent Insiders 1.54 | Percent Institutions 108.72 |
Upturn AI SWOT
Evolent Health Inc

Company Overview
History and Background
Evolent Health Inc. was founded in 2011. It emerged from The Advisory Board Company and Valence Health to focus on population health management. It evolved to offer administrative simplification and clinical decision support to healthcare organizations.
Core Business Areas
- Evolent Value-Based Care: Provides technology and services that support risk-bearing entities in managing populations under value-based care arrangements. It include end-to-end management of payer and provider-sponsored health plans.
- New Century Health: Specialty care management focused on oncology and cardiology. New Century Health was acquired by Evolent Health in 2018 and offers comprehensive clinical programs.
- Administrative Simplification: Offers administrative and financial solutions to streamline healthcare operations and reduce costs for healthcare providers.
Leadership and Structure
Evolent Health is led by CEO John Johnson. The organizational structure is designed around its core business areas, with dedicated teams for value-based care, specialty care management, and administrative services. There is a Chief Financial Officer, a Chief Medical Officer, and other executives overseeing different aspects of the business.
Top Products and Market Share
Key Offerings
- Evolent Value-Based Care Platform: A technology platform that supports value-based care programs. It is difficult to pinpoint exact market share figures due to the fragmented nature of the healthcare technology market, but Evolent's platform serves a significant number of health plans and provider organizations. Competitors include Cerner, Optum, and Allscripts.
- New Century Health Specialty Care Management: Specialty care management services focused on oncology and cardiology, helping to ensure appropriate and cost-effective care. Competitors include AIM Specialty Health (Anthem) and eviCore healthcare (Elevance Health).
Market Dynamics
Industry Overview
The healthcare industry is undergoing significant transformation, driven by the shift to value-based care, increasing regulatory pressures, and the need to improve efficiency and reduce costs. There is increasing demand for clinical decision support and administrative simplification tools.
Positioning
Evolent Health positions itself as a partner to health plans and providers, offering integrated technology and services to help them succeed in value-based care arrangements. Its competitive advantages include its comprehensive suite of solutions and its expertise in managing populations under risk-based contracts.
Total Addressable Market (TAM)
The TAM for value-based care and healthcare technology is estimated to be worth hundreds of billions of dollars. Evolent Health is positioned to capture a portion of this market through its technology, services, and partnerships.
Upturn SWOT Analysis
Strengths
- Comprehensive suite of solutions
- Expertise in value-based care
- Strong partnerships with health plans and providers
- Technology-enabled platform
- Acquisition of New Century Health providing further expansion
Weaknesses
- Dependence on key partnerships
- Competition from larger players
- Integration challenges with acquired companies
- Limited brand recognition compared to larger competitors
Opportunities
- Expanding adoption of value-based care models
- Increasing demand for healthcare technology solutions
- Strategic acquisitions to expand service offerings
- Partnerships with new health plans and provider organizations
- Further development of administrative simplification tools
Threats
- Changes in healthcare regulations
- Increased competition from established players
- Economic downturn affecting healthcare spending
- Technological obsolescence
- Data security breaches
Competitors and Market Share
Key Competitors
- UNH
- CI
- THC
- OPCH
Competitive Landscape
Evolent Health competes with larger, more established players in the healthcare technology and services market. Evolent's competitive advantages include its comprehensive suite of solutions and its expertise in managing populations under risk-based contracts. Its disadvantages include its limited brand recognition and smaller size compared to its competitors.
Major Acquisitions
New Century Health
- Year: 2018
- Acquisition Price (USD millions): 675
- Strategic Rationale: To expand its specialty care management capabilities and provide a more comprehensive suite of solutions to health plans and providers.
Growth Trajectory and Initiatives
Historical Growth: Evolent Health has experienced growth in revenue and customer base driven by the increasing adoption of value-based care. Growth rates would be indicated as: Revenue Growth Rate = [0.15, 0.12, 0.10].
Future Projections: Analyst estimates project continued growth for Evolent Health, driven by the increasing demand for value-based care solutions. The estimated future growth is [0.10,0.12]
Recent Initiatives: Recent initiatives include expanding partnerships with health plans and providers, investing in technology development, and pursuing strategic acquisitions.
Summary
Evolent Health is a player in the value-based care market, demonstrating growth through strategic acquisitions and comprehensive service offerings. The company's strengths lie in its technology and expertise in managing risk-based contracts. However, it faces competition from larger, established players. Future success depends on continued innovation, successful integration of acquisitions, and expanding its market reach.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q)
- Analyst reports
- Press releases
- Industry publications
Disclaimers:
The data provided is for informational purposes only and should not be considered as investment advice. Market share figures are estimates and may vary. Financial data is based on publicly available information and may be subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Evolent Health Inc
Exchange NYSE | Headquaters Arlington, VA, United States | ||
IPO Launch date 2015-06-05 | Co-Founder, CEO & Director Mr. Seth Barrie Blackley | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4500 | Website https://www.evolent.com |
Full time employees 4500 | Website https://www.evolent.com |
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.